Skip to main content

Table 2 Detailed schedule of assessments during follow up

From: Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes

Follow up Screening Baseline In the first month In the second month In the fourth month After six months In the eighth month In the tenth month In the twelfth month After twelve months
  T0 T1 T2 T3 T4 T5 T6 T7 T8
Participant characteristics X          
Medical history X          
Anthropometrics X X X X X X X X X X
Blood pressure X X X X X X X X X X
Medication dosage X X     X     X
Adverse Events   X     X     X
Serious Adverse Events   X X X X X X X X X
MRI   X     X     X
Stool sample (including registration form)   X X    X     X
Finger-stick ketone bodies test   X X   X   X   X  
Questionnaires
 Cost questionnaire      X X   X   X
 Quality of Life (EQ-5D-5L)   X    X X   X   X
 Treatment satisfaction (DTSQs)   X    X X   X   X
 Treatment satisfaction (DTSQc)           X
 Eating habits (DHD-FFQ)   X     X     X
 Physical activity (SQUASH)   X     X     X
 MRI safety questionnaire X X     X     X
Fasting blood sample
 HbA1c X X     X     X
 Glucose X X X   X X X   X X
 Creatinin X          
 ASAT X          
 ALAT X          
 Haemoglobin X          
 Red cell indices X          
 Leucocytes X          
 Thrombocytes X          
 OGTT (5x glucose and 5x insulin)   X     X     X
 Total cholesterol   X     X     X
 Low-density lipoprotein (LDL)   X     X     X
 High-density lipoprotein (HDL)   X     X     X
 Triglycerides   X     X     X
 High sensitive CRP   X     X     X
 Metabolomics   X         X
 IGF-1a   X X   X   X   X  
 Insulin-like growth factor-binding protein (IGF-BP-1)a   X X   X   X   X  
  1. Laboratory tests with a a will only be performed in the FMD group